ClinicalTrials.Veeva

Menu

Endocrine Determinants of Renal Function in Patients With Hypoparathyroidism (ENDORSE)

S

San Donato Group (GSD)

Status

Completed

Conditions

Hypoparathyroidism

Treatments

Diagnostic Test: Blood sample and urine collection

Study type

Observational

Funder types

Other

Identifiers

NCT06449729
BP 11006333

Details and patient eligibility

About

Endocrine determinants of renal function in patients with hypoparathyroidism on conventional treatment: a cross-sectional study (ENDORSE)

Enrollment

46 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age ≥ 18 years
  • diagnosis of chronic (≥ 1 year) post-surgical and autoimmune hypoparathyroidism, as established with undetectable or insufficient PTH concentration in relation to the presence of hypocalcemia
  • patients being treated with calcitriol or alfacalcidiol
  • patients able to sign the written informed consent

Exclusion criteria

  • pregnancy
  • severe renal failure requiring dialysis treatment
  • macroproteinuria
  • use of antihypertensive drugs such as thiazides, ACE inhibitors, sartans, beta and alpha blockers, and antialdosterone drugs
  • pazients affected by diabetes mellitus- insulin-treated

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems